Photocure ASA

Photocure ASA: Share capital increase registered

Oslo, Norway, 16 March 2022: Reference is made to the stock exchange release by

Photocure ASA ("Photocure" or the "Company") published on 14 March 2022

regarding a share capital increase following the exercise of share options.

The issuance of 2,750 new shares has been registered with the Norwegian Register

of Business Enterprises. Following registration, the share capital of Photocure

is NOK 13,488,285 divided into 26,976,570 shares, each share having a par value

of NOK 0.50 and carrying one vote in the Company's general meeting.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000

About Photocure ASA:

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com or www.cysview.com. All trademarks mentioned

in this release are protected by law and are registered trademarks of Photocure

ASA. This information is subject to the disclosure requirements pursuant to

sections 5-12 of the Norwegian Securities Trading Act.

AI Terminal